Putting the safety issue to bed, Aurinia's late-stage lupus nephritis data shines
After a checkered mid-stage program marred by patient deaths, Aurinia emerged victorious on Wednesday with Phase III lupus nephritis data that demonstrated its lead …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
